ARCHIVES

Five Awards Expected In Annual CCP Review; 21 Applicants Compete For Limited Funding

This article is from The Cancer Letter archive.

Vol. 17 No. 05 | February 1, 1991

Download PDF Visit The Full Archive

Related Articles

European Commission Approves Subcutaneous Rituximab

March 28, 2014

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992

NSABP Accrual To Resume Soon; Group ponders Elections, Move To Fox Chase

May 27, 1994

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

Some Of Show’s Screening Messages Not Widely Accepted.

September 12, 2008

NIH, NCI Being Discussions With HCFA On Reimbursement

April 26, 1996